DaVita Reports Strong Q1 Earnings, Significant Share Repurchases, and Strategic Acquisition
Summary
DaVita Inc. reported strong first-quarter 2026 financial results with significant year-over-year growth in net income and diluted EPS, alongside substantial share repurchases and a strategic acquisition, providing detailed financials following an earlier 8-K announcement.
Key Events
-
Strong Q1 2026 Financial Performance
Net income attributable to DaVita Inc. increased by 21.2% to $197.53 million, and diluted EPS grew by 43.5% to $2.87 for Q1 2026 compared to Q1 2025. Total revenues rose 6.0% year-over-year to $3.42 billion.
-
Significant Share Repurchases
The company repurchased 3.01 million shares for $402.86 million during Q1 2026. Subsequent to quarter-end through May 5, 2026, an additional 2.01 million shares were repurchased for $301.81 million, including the settlement of a $182.87 million obligation to Berkshire Hathaway Inc. The company has $1.46 billion remaining under current repurchase authorizations.
-
Improved Cash Flow from Operations
Net cash provided by operating activities significantly increased by 78.2% to $320.83 million for Q1 2026 compared to the prior year, with free cash flow improving from a negative $45 million to a positive $140 million.
-
Strategic Minority Interest Acquisition
On February 2, 2026, DaVita signed a definitive agreement to acquire a noncontrolling minority interest in Elara Caring, a national provider of home health, hospice, behavioral health, and personal care services, for approximately $200 million, with closing expected mid-year 2026.
Analysis
This 10-Q filing provides comprehensive details following the company's earlier 8-K announcement of strong first-quarter results and raised guidance. The report confirms robust financial performance, highlighted by substantial year-over-year growth in net income and diluted EPS. The significant share repurchase activity, totaling over $700 million in Q1 and subsequent periods, demonstrates strong capital allocation and management confidence, especially as the stock trades near its 52-week high. The strategic acquisition of a minority interest in Elara Caring further signals growth initiatives. While the headline numbers were pre-released, the detailed financial statements and management's discussion offer critical insights into the company's operational health and future outlook, making this a very important filing for investors.
At the time of this filing, DVA was trading at $163.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $10.4B. The 52-week trading range was $101.00 to $159.42. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.